{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:34:54Z","timestamp":1790386494640,"version":"4.1.0"},"reference-count":171,"publisher":"American Society for Clinical Investigation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,4]]},"DOI":"10.1172\/jci122287","type":"journal-article","created":{"date-parts":[[2019,3,3]],"date-time":"2019-03-03T18:00:47Z","timestamp":1551636047000},"page":"1407-1418","source":"Crossref","is-referenced-by-count":108,"title":["Oncolytic viruses: overcoming translational challenges"],"prefix":"10.1172","volume":"129","author":[{"given":"Jordi","family":"Martinez-Quintanilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7843-1917","authenticated-orcid":false,"given":"Ivan","family":"Seah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0015"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2016-0129"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00555","article-title":"Oncolytic immunotherapy: conceptual evolution, current strategies, and future perspectives","volume":"8","author":"Guo","year":"2017","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.03.011"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0736"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.3675"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70107-4"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.3377"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301885"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008095"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.07.006"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301377"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7701080"},{"issue":"pt 8","key":"B14","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1099\/vir.0.043281-0","article-title":"Extracellular matrix constituents interfere with Newcastle disease virus spread in solid tissue and diminish its potential oncolytic activity","volume":"93","author":"Yaacov","year":"2012","journal-title":"J Gen Virol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2010.02.014"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.79"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10668"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.204"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2213"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1899"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147211"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-366","article-title":"Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors","volume":"12","author":"Sch\u00e4fer","year":"2012","journal-title":"BMC Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj397"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2017.03.009"},{"issue":"9","key":"B25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3727\/096504013X13657689383139","article-title":"Therapeutic effect of oncolytic adenovirus expressing relaxin in radioresistant oral squamous cell carcinoma","volume":"20","author":"Lee","year":"2013","journal-title":"Oncol Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2014.110"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3726"},{"key":"B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800092-2.00001-0","article-title":"Emerging roles for hyaluronidase in cancer metastasis and therapy","volume":"123","author":"McAtee","year":"2014","journal-title":"Adv Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3753"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.605"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.94"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2013.806484"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210189"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700607"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3892\/or.2014.3020"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25808"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.11.10.1299"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.175"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30811"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/75045"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22328"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.21"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3089"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-2762"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0488"},{"issue":"Pt 11","key":"B47","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/0022-1317-81-11-2605","article-title":"Blood clearance rates of adenovirus type 5 in mice","volume":"81","author":"Alemany","year":"2000","journal-title":"J Gen Virol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1510"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2012.31"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2005.16.664"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052306"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2014.07.028","article-title":"Corrigendum to \u201cAntibody neutralization of retargeted measles viruses\u201d [Virology 454-455 (2014) 237-246]","volume":"464-465","author":"Lech","year":"2014","journal-title":"Virology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1080\/10611860701501014"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1021\/bm501116x"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2004.01.018"},{"issue":"2","key":"B56","first-page":"555","article-title":"A phase I\/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma","volume":"9","author":"Hecht","year":"2003","journal-title":"Clin Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/78638"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0477"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2015.098"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nature10358"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300215"},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00353","article-title":"Recognition of human oncogenic viruses by host pattern-recognition receptors","volume":"5","author":"Di Paolo","year":"2014","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2008.80"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302445"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2011.141"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.147"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2010.02.004"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2013.03.057"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00241-1"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nm0806-875"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700801"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20013"},{"issue":"7","key":"B73","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1182\/blood.V83.7.1799.1799","article-title":"Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity","volume":"83","author":"Thalmeier","year":"1994","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.45"},{"issue":"6","key":"B75","first-page":"1523","article-title":"Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer","volume":"5","author":"Coukos","year":"1999","journal-title":"Clin Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2703"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3303098"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2009.29"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2011.91"},{"issue":"4","key":"B80","first-page":"951","article-title":"Cross-infection of tumor cells by contact with T lymphocytes loaded with Newcastle disease virus","volume":"34","author":"Pfirschke","year":"2009","journal-title":"Int J Oncol"},{"key":"B81","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2015.14","article-title":"Chimeric antigen receptor-engineered T cells as oncolytic virus carriers","volume":"2","author":"VanSeggelen","year":"2015","journal-title":"Mol Ther Oncolytics"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nm1681"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.194"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.010"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-017-0480-8"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21444"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3056"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2013.763925"},{"key":"B89","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-11-20","article-title":"Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer","volume":"11","author":"Mader","year":"2013","journal-title":"J Transl Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1080\/14653240802486517"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2007-0758"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2007.034"},{"issue":"6","key":"B93","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju090","article-title":"Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy","volume":"106","author":"Duebgen","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-017-0593-3"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2018.0058"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2012-0175"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-0431"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.5.557"},{"issue":"2","key":"B99","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nn.3019","article-title":"Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas","volume":"15","author":"Kauer","year":"2011","journal-title":"Nat Neurosci"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1700363114"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2014.72"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2011.100"},{"issue":"375","key":"B103","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah6510","article-title":"Tumor-homing cytotoxic human induced neural stem cells for cancer therapy","volume":"9","author":"Bag\u00f3","year":"2017","journal-title":"Sci Transl Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2000.0046"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.265"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.40"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.179"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02668-13"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1355"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7253-1_35"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2016.02.025"},{"key":"B112","first-page":"193","article-title":"Ultrasound-mediated oncolytic virus delivery and uptake for increased therapeutic efficacy: state of art","volume":"4","author":"Nande","year":"2015","journal-title":"Oncolytic Virother"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2015.3"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt305"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.08.027"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.07.012"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3770"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-100008"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6265"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2733"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.115"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0334"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3848"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.06.009"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.04.020"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox038"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2017.12.001"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-018-0020-7"},{"key":"B129","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00866","article-title":"Oncolytic viral therapy and the immune system: a double-edged sword against cancer","volume":"9","author":"Marelli","year":"2018","journal-title":"Front Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.2217\/imt.13.65"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.07.097"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2546"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.2174\/138920112800958922"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0809-6"},{"issue":"1","key":"B135","article-title":"First oncolytic viral therapy for melanoma","volume":"6","author":"Poh","year":"2016","journal-title":"Cancer Discov"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.2217\/imt.15.116"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0759"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24522"},{"issue":"12","key":"B139","first-page":"1372","article-title":"JX-594, a targeted oncolytic poxvirus for the treatment of cancer","volume":"10","author":"Merrick","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2011.132"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2727-2_19"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.109"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.312"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e318193d31e"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-012-1279-4"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1593\/neo.121272"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2017.06.002"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2011.37"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0935"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not317"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081768"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-1708"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0979"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00343-07"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.154"},{"issue":"12","key":"B156","first-page":"1129","article-title":"Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumors","volume":"1","author":"Mulryan","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305133"},{"issue":"4","key":"B158","first-page":"66","article-title":"B7-H3 role in the immune landscape of cancer","volume":"6","author":"Castellanos","year":"2017","journal-title":"Am J Clin Exp Immunol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.01.007"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709030"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30422-9"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2016.70"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-652503"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1008824"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.156"},{"key":"B167","article-title":"Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.1529"},{"issue":"suppl_15","key":"B169","article-title":"Final data from CALM: A phase II study of Coxsackievirus A21 (CVA21) oncolytic virus immunotherapy in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J Clin Oncol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1037058"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq048"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jci.org\/articles\/view\/122287\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T13:25:57Z","timestamp":1691069157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jci.org\/articles\/view\/122287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":171,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,1]]},"published-print":{"date-parts":[[2019,4,1]]}},"alternative-id":["10.1172\/JCI122287"],"URL":"https:\/\/doi.org\/10.1172\/jci122287","relation":{},"ISSN":["0021-9738","1558-8238"],"issn-type":[{"value":"0021-9738","type":"print"},{"value":"1558-8238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]}}}